About the Early Detection, Screening & Prevention Session
Early detection and prevention remain central to reducing cancer incidence, morbidity, and mortality. This session explores advances in cancer screening, risk assessment, preventive strategies, early diagnostic approaches, and technologies aimed at identifying malignancies at their earliest and most treatable stages. It also considers genetic, environmental, behavioral, and population-level factors that influence cancer risk.
Abstract Scope and Participation
Abstracts are welcomed on cancer screening, early diagnosis, risk prediction, prevention, precancerous conditions, population screening programs, novel detection technologies, and related clinical or public-health approaches. Researchers, clinicians, epidemiologists, public-health professionals, and specialists involved in cancer prevention and early detection are encouraged to participate.
Topics Covered in Early Detection, Screening & Prevention
Topic 01
Cancer Screening
Topic 02
Early Diagnosis
Topic 03
Cancer Prevention
Topic 04
Risk Assessment
Topic 05
Population Screening
Topic 06
Detection Technologies
Featured Speakers — Early Detection, Screening & Prevention 2027
Recent Research Presented at Early Detection, Screening & Prevention Sessions
Impact of normalization strategies on the diagnostic performance of salivary microRNAs for early detection of oral squamous cell carcinoma: A systematic review, diagnostic meta-analysis, and meta-regression
Salivary microRNAs (miRNAs) are promising non-invasive biomarkers for the early detection of oral squamous cell carcinoma (OSCC), but variability in normalization strategies limits their…
Nanoparticle-based chemiluminescent detection of an ovarian cancer biomarker – A clinically-relevant pilot study
Biomarker based detection for ovarian cancer (OC) in clinical settings is currently focused on the biomarker CA-125. This marker unfortunately has a fairly low sensitivity and specificity for ovarian…
Multiplexed biosensor detection of cancer biomarkers
Biosensor technology represents an attractive strategy for the detection and monitoring of biomarkers for disease states within the context of precision medicine. In the present paper we discuss the…
Radosavljevic's urinary screening biomarkers of the key chemical carcinogens for bladder cancer
The aim of the study was to examine the possibility of using the urinary concentration of 1-hydroxypyrene for screening high-risk male individuals for bladder cancer. Radosavljevi?′s urinary…
AI guided navigation of high risk incidental findings on imaging studies leads to cancer diagnoses
Introduction : Artificial Intelligence (AI) is a burgeoning tool in the field of surgery. AI technology is vastly unexplored with few applications currently in use. High risk incidental findings in…
Biosensor-based detection of cancer biomarkers
Biosensor technology represents an attractive strategy for the detection and monitoring of biomarkers for disease states within the context of precision medicine. This approach offers the possibility…
Related Scientific Sessions at CIOC 2027
Why Attend the Early Detection, Screening & Prevention Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Early Detection, Screening & Prevention work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Early Detection, Screening & Prevention research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Early Detection, Screening & Prevention track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Early Detection, Screening & Prevention Conference 2027 — FAQs
What is the Early Detection, Screening & Prevention track at CIOC 2027?
The Early Detection, Screening & Prevention track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Early Detection, Screening & Prevention. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Early Detection, Screening & Prevention sessions?
Cancer researchers and clinicians, educators and students with an interest in Early Detection, Screening & Prevention are all welcome — whether presenting or attending.
Can I present my research in the Early Detection, Screening & Prevention track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Early Detection, Screening & Prevention sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Early Detection, Screening & Prevention track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Register as Delegate →
Attend without presenting.